The new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM)
Stenocare This week the Danish medical cannabis company unveiled its unaudited Q4 and full year results, seeing sales more than
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15. The
SIGNIFICANT developments from Germany this week helped add to the momentum of interest in cannabis stocks initially driven by President
Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May
AFTER securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and
STENOCARE has seen double digit price rises across both the Copenhagen NASDAQ and the Frankfurt Stock Exchange, jumping 17.5% and
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears
STENOCARE A/S (“STENOCARE”) to make medical cannabis oil products available for UK patients. With this STENOCARE is taking a major step towards its goal of
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
